David Ferrera is a medical device engineer, entrepreneur and inventor with nearly 30 years of experience in neurovascular and interventional medicine.
Based in Lake Forest, California, he has built a career focused on turning clinical ideas into real products that improve patient care.
He began his career at Boston Scientific before moving on to more specialized positions in vascular and neurovascular technology. Over time, he co-founded and led several companies, including Micrus Endocular, MindFrame and Blockade Medical. Each company focused on solving specific problems in stroke treatment and interventional procedures. These companies were later acquired by major industry players such as Johnson & Johnson, Terumo, Covidien and Balt.
Ferrera is now CEO of RC Medical, a venture studio that works with doctors to develop and commercialize new medical devices. He is also CEO and Chairman of Sonorous Neuro. His work focuses on building structured, milestone-driven companies that address real clinical needs.
He holds more than 80 U.S. and international patents and is the author of “Innovation in Translation,” published by Advantage-Forbes. His approach is based on discipline, clear problem definition and practical implementation.
Beyond his professional work, Ferrera was active in philanthropy, serving as chairman of the American Heart Association’s Orange County Heart & Stroke Ball. His career reflects a consistent focus on developing solutions that extend from concept to clinical application.
David Ferrera on building what actually works in medical technology
Q: How did your career in medical devices begin?
I started at Boston Scientific in the early 1990s. I had a background in plastics engineering, so I was fascinated by how materials and design could solve medical problems. It became clear to me early on that the field was moving quickly, but only if products actually worked in real-world processes.
Q: What was your first big step into leadership?
Co-founding Micrus Endovascular was a turning point. We focused on neurovascular devices. At this point the space was still under development. We had to develop technology while proving clinical value. This company was later acquired by Johnson & Johnson, which gave me a clear view of how larger companies evaluate products.
Q: What have you learned from your time at MindFrame?
At MindFrame, I led product development and clinical research. We worked on one of the first mechanical thrombectomy systems to treat strokes. I remember cases where time was of the essence. Every delay counted. That shaped my attitude towards design. A device is not just about function. It’s about the workflow.
Q: You have been involved in several acquisitions. How did that shape your approach?
Each acquisition reinforced the same lesson. You need structure from the start. Regulatory planning, manufacturing and clinical data cannot be afterthoughts. If these parts are not aligned early on, the company will face difficulties later.
Q: Why did you decide to build RC Medical as a venture studio?
After building individual companies, I wanted a more repeatable model. At RC Medical, we work with doctors who see problems every day. We validate early. We build in stages. We keep teams lean. It allows us to work on multiple ideas while maintaining discipline.
Q: How do physician partnerships influence your work?
They are essential. Doctors understand where procedures fail. A doctor once showed me a case in which a device had to be replaced several times. It took several minutes. This insight led to a redesign focused on reducing steps. This is where real innovation happens.
Q: What role does Sonorous Neuro play in your current work?
Sonorous Neuro is one of the companies that was created using this model. I am CEO and Chairman. The focus is on neurovascular care. We are working to improve the delivery of interventions, particularly stroke interventions. It’s about precision and efficiency.
Q: What challenges have you faced in recent years?
Regulatory expectations have increased. Capital is more selective. You can’t rely on dynamics alone. You need clear milestones and meaningful data. This has made discipline even more important.
Q: How do you stay close to what matters locally?
I spend time with doctors. I review clinical data. I focus on what happens in the treatment rooms, not just what is presented at conferences. Real feedback comes from real usage.
Q: How has your leadership style changed over time?
From an early age I focused heavily on technical details. Over time, I moved on to alignment. Clear goals. Clear responsibility. Teams perform better when expectations are simple and direct.
Q: What advice would you give to someone entering this space?
Start with the problem, not the technology. Take time to understand clinical needs. Then build with discipline. Big ideas are common. The hard part is turning them into working products.
